| Description |
Using the SAFE™ Standard to Create Fully Electronic Business-to-regulator and Business-to-business Processes
A move toward fully electronic processes will open the door for productivity increases, as well as cost and cycle time savings for the biopharmaceutical industry. To achieve these benefits, however, the industry must trust the identities of those transmitting and receiving data, the legal and regulatory acceptance of the digital signatures, the secure transmission of information, and the interoperability among different technologies.
CONFERENCE HIGHLIGHTS
Topics will include:
•The SAFE™ standard defined
•Implementation of regulatory, clinical, legal, HR, commercial, and other projects utilizing SAFE™ digital signatures
•Vendors using SAFE™-enabled applications
•Regulatory and legal perspectives of the SAFE™ standard
•Technical requirements for SAFE™ implementation
•Benefits of the SAFE™ standard.
|
|
